709 Exosome surface display of IL-12 results in tumor-retained pharmacology with superior potency and limited systemic exposure

by Michael Doherty, Ke Xu, Tong Zi, Sriram Sathyanaryanan, Nuruddeen Lewis, Chang Ling Sia, Katherine Kirwin, Sonya Haupt, Gauri Mahimkar, Kevin Dooley, Su Chul Jang, Bryan Choi, Andrew Grube, Christine McCoy, Jorge Sanchez-Salazar, Scott Estes, Kyriakos Economides, Douglas Williams
Published 2020-11-01